Showing 171-180 of 9721 results for "".
ILUMYA SUPPORT™ patient access for commercial and Medicare Part B patients
https://practicaldermatology.com/topics/psoriasis/ilumya-support-patient-access-for-commercial-and-medicare-part-b-patients/19860/ILUMYA SUPPORT™ offers comprehensive programs and services to help patients start and stay on therapy with ILUMYA™. Learn about the three main patient access programs offered by ILUMYA SUPPORT™: the Early Access Program, the Co-pay Program, and the Patient Assistance Program. ILUMYA™ is reimbursed uProviding Quality Customer Service Behind the Mask
https://practicaldermatology.com/topics/practice-management/providing-quality-customer-service-behind-the-mask/23400/Eight ways to make a good impression and provide excellent customer service.The Importance of a Broad Social Media Presence in Dermatology
https://practicaldermatology.com/topics/practice-management/the-importance-of-a-broad-social-media-presence-in-dermatology/23399/Meet your current and potential patients on the social media platforms they prefer.DermWireTV: Cassiopeia Winlevi; Psoriasis Guidelines; Cyndi Lauper's PsO in the Know; Sarah Michelle Gellar's CoolSculpting
https://practicaldermatology.com/topics/psoriasis/dermwiretv-cassiopeia-winlevi-psoriasis-guidelines-cyndi-laupers-pso-in-the-know-sarah-michelle-gellars-coolsculpting/19852/The FDA has approved Winlevi (Clascoterone cream 1%) from Cassiopea for the treatment of acne in patients 12 years and older.New Guidelines of care for the Management of Psoriasis with Systemic Nonbiologic Therapies, jointly issued by the American Academy of Dermatology and the National Psoriasis FoCOVID-19 Will Eventually End, But Telemedicine is Here to Stay
https://practicaldermatology.com/topics/practice-management/covid-19-will-eventually-end-but-telemedicine-is-here-to-stay/23348/As dermatology practices consider next steps regarding virtual care visits, it’s important to look beyond the basic platforms and establish a safer, more userfriendly telemedicine strategy.How Does Consideration of the Microbiome Affect Topical Product Selection
https://practicaldermatology.com/topics/atopic-dermatitis/how-does-consideration-of-the-microbiome-affect-topical-product-selection/19827/A healthy microbiome is a hallmark of healthy skin, while dysbiosis is implicated in various dermatologic diseases. Dr. Friedman explains how this knowledge should influence topical skin care.Setting Compensation Expectations for Non-Surgical Providers
https://practicaldermatology.com/topics/practice-management/setting-compensation-expectations-for-non-surgical-providers/23227/It’s important that all parties understand the actual costs associated with a position in order to set realistic revenue goals.Social Media Use By Medical Providers: Risk, Benefit, Ethical Quandaries
https://practicaldermatology.com/topics/practice-management/social-media-use-by-medical-providers-risk-benefit-ethical-quandaries/23174/Those who treat patients may use social media in professional settings, but caution is in order.How to Get Job Seekers to Apply to Your Job
https://practicaldermatology.com/topics/practice-management/how-to-get-job-seekers-to-apply-to-your-job/23152/Learn the secrets to getting qualified physicians to apply to your job.Systemic Treatment for Skin Cancers
https://practicaldermatology.com/topics/skin-cancer-photoprotection/systemic-treatment-for-skin-cancers/19662/Anisha B. Patel, MD discusses the latest advances in systemic treatment for melanoma with host Joshua Zeichner, MD. She reviews how treatments work, the most common cutaneous reactions patients experience, and the dermatologist's role in managing those reactions and reassuring patients that these re